11-101583475-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS2_Supporting

The NM_004621.6(TRPC6):​c.29G>A​(p.Arg10Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000367 in 1,363,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. R10R) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000037 ( 0 hom. )

Consequence

TRPC6
NM_004621.6 missense

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.80

Publications

0 publications found
Variant links:
Genes affected
TRPC6 (HGNC:12338): (transient receptor potential cation channel subfamily C member 6) The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]
TRPC6 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25315732).
BS2
High AC in GnomAdExome4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRPC6NM_004621.6 linkc.29G>A p.Arg10Gln missense_variant Exon 1 of 13 ENST00000344327.8 NP_004612.2 Q9Y210-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPC6ENST00000344327.8 linkc.29G>A p.Arg10Gln missense_variant Exon 1 of 13 1 NM_004621.6 ENSP00000340913.3 Q9Y210-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000161
AC:
2
AN:
123968
AF XY:
0.0000294
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000913
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000367
AC:
5
AN:
1363642
Hom.:
0
Cov.:
31
AF XY:
0.00000448
AC XY:
3
AN XY:
669130
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29252
American (AMR)
AF:
0.0000597
AC:
2
AN:
33514
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24150
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34394
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41706
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5076
European-Non Finnish (NFE)
AF:
0.00000282
AC:
3
AN:
1062022
Other (OTH)
AF:
0.00
AC:
0
AN:
56448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 10, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
0.011
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T;.;.;.
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.095
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.25
T;T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
0.55
N;.;N;N
PhyloP100
3.8
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.41
N;N;N;N
REVEL
Uncertain
0.31
Sift
Uncertain
0.016
D;D;D;D
Sift4G
Benign
0.25
T;T;T;T
Polyphen
0.21
B;.;B;B
Vest4
0.25
MutPred
0.30
Loss of MoRF binding (P = 0.0105);Loss of MoRF binding (P = 0.0105);Loss of MoRF binding (P = 0.0105);Loss of MoRF binding (P = 0.0105);
MVP
0.78
MPC
0.34
ClinPred
0.34
T
GERP RS
5.2
PromoterAI
-0.024
Neutral
Varity_R
0.17
gMVP
0.41
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1227678536; hg19: chr11-101454206; API